← All trials
NCT06947499
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 30, 2025
- Primary completion
- Nov 30, 2026
- Completion date
- Apr 30, 2027
- First posted
- Apr 27, 2025
- Last posted
- Jul 3, 2025
- Enrollment
- 1186
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LGLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.